Please visit Boston University School of Medicine’s Amyloidosis Center website for more information about the different types, the patient evaluation process, and consultation services.

Boston Medical Center is an international referral center for the diagnosis and treatment of amyloidosis, a rare group of diseases caused by the abnormal accumulation of the protein amyloid in various parts of the body. This can occur as part of a bone marrow plasma cell disorder (AL), as a hereditary form (AF), an age-related form (senile systemic amyloidosis due to ATTR), or secondary to chronic inflammatory or infectious diseases (AA).

The Amyloidosis Center at BMC offers a multi-disciplinary approach to diagnosis and treatment of this multi-organ disorder. Under the direction of Vaishali Sanchorawala, MD, the Center is unique in its approach, providing exceptional care for patients with all forms of systemic and localized amyloidosis through the support of laboratory and clinical research.

Specialists in hematology-oncologycardiologypulmonary medicinerenal medicinegastroenterologyneurologyotolaryngologypathology and laboratory medicineurology, and radiation oncology coordinate to evaluate patients and develop care plans.

The disease frequently involves more than one organ system. For this reason, Boston Medical Center offers a multispecialty evaluation for patients. This is a three day, outpatient evaluation comprised of a number of tests and consultations which will help determine the amyloid type and organ system involvement. Patients are guided through each step of the evaluation, with doctors and nurses explaining why each test is being done and what the results mean.

Once the evaluation is complete, a treatment plan is developed.

Medical and pathological consultation services are also available to patients and doctors.

Contact Us

Our Team

The amyloidosis clinical team is a multidisciplinary group of physicians at Boston Medical Center. Each sub-specialist is an amyloid expert and has seen hundreds of patients with amyloidosis.

John L Berk, MD

Associate Professor of Medicine, Boston University School of Medicine, Boston MA
Placeholder image for doctor

Andrea I Havasi, MD

Assistant Professor of Medicine, Boston University School of Medicine, Boston MA

Tracy A Joshi, DNP

Special Interests

Amyloidosis, AL Amyloidosis, Transthyretin Amyloidosis, Localized Amyloidosis

Michelle Y Kaku, MD

Assistant Professor of Neurology, Boston University School of Medicine, Boston Massachusetts

Caryn A Libbey, MD

Associate Professor of Medicine, Boston University School of Medicine, Boston MA

Frederick L Ruberg, MD

Director, Advanced Cardiovascular Imaging Program Associate Director, Cardiovascular Fellowship Program Associate Professor of Medicine and Radiology, Boston University School of Medicine, Boston MA

John M Sloan, MD

Associate Professor of Medicine, Boston University School of Medicine

Lawreen H. Connors, Ph.D.
Department of Biochemistry
Department of Pathology and Laboratory Medicine

Research Overview

Patients with amyloidosis have been immeasurably aided through advances derived from laboratory and translational research programs coordinated by clinical investigators at BMC and laboratory investigators at Boston University School of Medicine (BUSM). The Center at BUSM has been in existence since 1960, and has been responsible for many advances in the field, including some of the first randomized treatment trials, stem cell transplant trials, trials with novel agents and small molecules, and protocols for liver and heart transplantation for selected patients. To learn about our research, please visit the Amyloidosis Center website at BUSM.

Latest from HealthCity

HealthCity is Boston Medical Center's online publication that explores the most pressing issues in healthcare. At HealthCity, we believe that healthcare must transform itself to become more equitable, sustainable, and open source.